- Home
- PLBY vs RLYB Comparison
PLBY vs RLYB Comparison
Compare PLBY & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLBY | RLYB |
|---|---|---|
| Founded | 1953 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.8M | 24.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLBY | RLYB |
|---|---|---|
| Price | $1.87 | $0.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 196.0K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $119,510,000.00 | $674,000.00 |
| Revenue This Year | $4.97 | $17.61 |
| Revenue Next Year | $8.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.71 |
| 52 Week Low | $0.90 | $0.22 |
| 52 Week High | $2.53 | $1.08 |
Technical Indicators
Market Signals| Indicator | PLBY | RLYB |
|---|---|---|
| Relative Strength Index (RSI) | 50.70 | 63.06 |
| Support Level | $1.72 | $0.71 |
| Resistance Level | $2.53 | $0.80 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 17.90 | 82.82 |
Price Performance
Historical ComparisonAbout PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.